Colorectal cancer liver metastasis: Local treatment for a systemic disease?

Annals of Oncology

Volumn 9, Issue 9, 1998, Pages 967-971

  Kohne C H ^a   Lorenz, M ^b   Herrmann, R ^c  

^a UNIVERSITY OF ROSTOCK   (Germany)

^b UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^c UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

Chemotherapy; Colorectal neoplasms; Liver metastasis; Surgery

Indexed keywords

FLOXURIDINE; FLUOROURACIL; FOLINIC ACID; INTERFERON; OXALIPLATIN;

CANCER ADJUVANT THERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL TRIAL; COLORECTAL CANCER; DRUG INFUSION; HUMAN; IMMUNOMODULATION; INTRAARTERIAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LIVER FAILURE; LIVER METASTASIS; LIVER RESECTION; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROGNOSIS; REVIEW; TREATMENT OUTCOME;

ANTINEOPLASTIC AGENTS; CHEMOTHERAPY, ADJUVANT; COLORECTAL NEOPLASMS; COMBINED MODALITY THERAPY; HUMANS; LIVER NEOPLASMS; NEOPLASM INVASIVENESS; POSTOPERATIVE CARE; SURVIVAL RATE;

EID: 0031733734     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1008463712683     Document Type: Review

References (54)

1. August DA, Ottow RT, Sugarbaker PH. Clinical perspective of human colorectal cancer metastasis. Cancer Metastasis Rev 1984; 3: 303-24.
2. Moertel CG, Fleming TR, Macdonald JS et al. Fluorouracil plus levamisole as effective adjuvant therapy after resection of stage III colon carcinoma: A final report. Ann Intern Med 1995; 122: 321-6.
3. Wolmark N, Rockette H, Fisher B et al. The benefit of leucovorin-modulated fluorouracil as postoperative adjuvant therapy for primary colon cancer: Results from National Surgical Adjuvant Breast and Bowel Project protocol C-03. J Clin Oncol 1993; 11: 1879-87.
4. Willett CG, Tepper JE, Cohen AM et al. Failure patterns following curative resection of colonic carcinoma. Ann Surg 1984; 200: 685-90.
5. Bengmark S, Hafstrom L, Jeppsson B et al. Metastatic disease in the liver from colorectal cancer: An appraisal of liver surgery. World J Surg 1982; 6: 61-5.
6. Wood CB, Gillis CR, Blumgart LH. A retrospective study of the natural history of patients with liver metastases from colorectal cancer. Clin Oncol 1976; 2: 285-8 No.
7. Vogl TJ, Muller P, Hirsch H et al. Laser-induced thermotherapy of liver metastases with MRI control. Prospective results of an optimized therapy procedure. Radiologe 1995; 35: 188-99.
8. Amin Z, Bown SG, Lees WR. Local treatment of colorectal liver metastases: A comparison of interstitial laser photocoagulation (ILP) and percutaneous alcohol injection (PAI). Clin Radiol 1993; 48: 166-71.
9. Nolsoe CP, Torp-Pedersen S, Burcharth F et al. Interstitial hyperthermia of colorectal liver metastases with a US-guided Nd-YAG laser with a diffuser tip: A pilot clinical study. Radiology 1993; 187: 333-7.
10. Fong Y, Cohen AM, Fortner JG et al. Liver resection for colorectal metastases. J Clin Oncol 1997; 15: 938-46.
11. Langenbuch C. Ein Fall von Resection eines linksseitigen Schnürlappens der Leber-Heilung. Berl Klin Wochenschr 1880; 19: 37-8.
12. Adson MA, van Heerden JA, Adson MH et al. Resection of hepatic metastases from colorectal cancer. Arch Surg 1984; 119: 647-51.
13. Fortner JG, Silva JS, Cox EB et al. Multivariate analysis of a personal series of 247 patients with liver metastases from colorectal cancer. II. Treatment by intrahepatic chemotherapy. Ann Surg 1984; 199: 317-24.
14. Butler J, Attiyeh FF, Daly JM. Hepatic resection for metastases of the colon and rectum. Surg Gynecol Obstet 1986; 162: 109-13.
15. Iwatsuki S, Esquivel CO, Gordon RD, Starzl TE. Liver resection for metastatic colorectal cancer. Surgery 1986; 100: 804-10.
16. Nordlinger B, Quilichini MA, Pare R et al. Hepatic resection for colorectal liver metastases. Influence on survival of preoperative factors and surgery for recurrences in 80 patients. Ann Surg 1987; 205: 256-63.
17. Schlag P, Hohenberger P, Herfarth C. Resection of liver metastases in colorectal cancer - competitive analysis of treatment results in synchronous versus metachronous metastases. Eur J Surg Oncol 1990; 16: 360-5.
18. Doci R, Gennari L, Bignami P et al. One hundred patients with hepatic metastases from colorectal cancer treated by resection: Analysis of prognostic determinants. Br J Surg 1991; 78: 797-801.
19. Scheele J, Stangl R, Altendorf-Hofmann A, Gall FP. Indicators of prognosis after hepatic resection for colorectal secondaries. Surgery 1991; 110: 13-29.
20. Rosen CB, Nagorney DM, Taswell HF et al. Perioperative blood transfusion and determinants of survival after liver resection for metastatic colorectal carcinoma. Ann Surg 1992; 216: 493-504.
21. Lorenz M, Staib-Sebler E, Koch B et al. The value of postoperative hepatic arterial infusion following curative liver resection. Anticancer Res 1997; 17: 3825-34.
22. Gayowski TJ, Iwatsuki S, Madariaga JR et al. Experience in hepatic resection for metastatic colorectal cancer: Analysis of clinical and pathologic risk factors. Surgery 1994; 116: 703-10.
23. Hughes KS, Simon R, Songhorabodi S et al. Resection of the liver for colorectal carcinoma metastases: A multi-institutional study of patterns of recurrence. Surgery 1986; 100: 278 84.
24. Nordlinger B, Guiguet M, Vaillant JC et al. Surgical resection of colorectal carcinoma metastases to the liver. A prognostic scoring system to improve case selection, based on 1568 patients. Association Francaise de Chirurgie. Cancer 1996; 77: 1254-62.
25. Panis Y, Ribeiro J, Chretien Y, Nordlinger B. Dormant liver metastases: An experimental study. Br J Surg 1992; 79: 221-3.
26. August DA, Sugarbaker PH, Ottow RT et al. Hepatic resection of colorectal metastases. Influence of clinical factors and adjuvant intraperitoneal 5-fluorouracil via Tenckhoff catheter on survival. Ann Surg 1985; 201: 210 8.
27. Curley SA, Roh MS, Chase JL, Hohn DC. Adjuvant hepatic arterial infusion chemotherapy after curative resection of colorectal liver metastases. Am J Surg 1993; 166: 743 6.
28. Elias D, Lasser P, Rougier P et al. Early adjuvant intraportal chemotherapy after curative hepatectomy for colorectal liver metastases a pilot study. Eur J Surg Oncol 1987; 13: 247-50.
29. Hodgson WJ, Friedland M, Ahmed T et al. Treatment of colorectal hepatic metastases by intrahepatic chemotherapy alone or as an adjuvant to complete or partial removal of metastatic disease. Ann Surg 1986; 203: 420-5.
30. Hughes K, Foster JH. The role of adjuvant chemotherapy following curative hepatic resection of colorectal metastases. Proc Am Soc Clin Oncol 1991; 10: 145 (Abstr).
31. Moriya Y, Sugihara K, Hojo K, Makuuchi M. Adjuvant hepatic intra-arterial chemotherapy after potentially curative hepatectomy for liver metastases from colorectal cancer: A pilot study. Eur J Surg Oncol 1991; 17: 519 25.
32. Klotz HP, Weder W, Largiader F. Local and systemic toxicity of intra-hepatic-arterial 5-FU and high-dose or low-dose leucovorin for liver metastases of colorectal cancer. Surg Oncol 1994; 3: 11-6.
33. Morrow CE, Grage TB, Sutherland DE, Najarian JS, Hepatic resection for secondary neoplasms. Surgery 1982; 92: 610-4.
34. O'Connell MJ, Adson MA, Schutt AJ et al. Clinical trial of adjuvant chemotherapy after surgical resection of colorectal cancer metastatic to the liver. Mayo Clin Proc 1985; 60: 517-20.
35. Patt YZ, McBride CM, Ames FC et al. Adjuvant perioperative hepatic arterial mitomycin C and floxuridine combined with surgical resection of metastatic colorectal cancer in the liver. Cancer 1987; 59: 867-73.
36. Wagman LD, Kemeny MM, Leong L et al. A prospective, randomized evaluation of the treatment of colorectal cancer metastatic to the liver. J Clin Oncol 1990; 8: 1885 93.
37. Schlag P, Manasterski M, Gerneth T et al. Active specific immunotherapy with Newcastle-disease-virus-modificd autologous tumor cells following resection of liver metastases in colorectal cancer. First evaluation of clinical response of a phase II-trial. Cancer Immunol Immunother 1992; 35: 325-30.
38. Lorenz M, Müller H, Schramm H et al. Interims-analysis of a prospective, randomised multicenter trial of the German Cooperative Group on Liver Metastases: Adjuvant intraarterial chemotherapy after curative resection of colorectal liver metastases. Langenbecks Arch Chir I 1998; 523 8.
39. Cohen AM, Kemeny NE, Kohne CH et al. Is intra-arterial chemotherapy worthwhile in the treatment of patients with unresectable hepatic colorectal cancer metastases? Eur J Cancer 1996; 32A: 2195-205.
40. Meta-analysis of randomized trials testing the biochemical modulation of fluorouracil by methotrexate in metastatic colorectal cancer. Advanced Colorectal Cancer Meta-Analysis Project. J Clin Oncol 1994; 12: 960-9.
41. Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: Evidence in terms of response rate. Advanced Colorectal Cancer Meta-Analysis Project. J Clin Oncol 1992; 10: 896-903.
42. Rougier P, Laplanche A, Huguier M et al. Hepatic arterial infusion of floxuridine in patients with liver metastases from colorectal carcinoma: Long-term results of a prospective randomized trial. J Clin Oncol 1992; 10: 1112-8.
43. Allen-Mersh TG, Earlam S, Fordy C et al. Quality of life and survival with continuous hepatic-artery floxuridine infusion for colorectal liver metastases. Lancet 1994; 344: 1255-60.
44. Reappraisal of hepatic arterial infusion in the treatment of non-resectable liver metastases from colorectal cancer. Meta-Analysis Group in Cancer. J Natl Cancer Inst 1996; 88: 252-8.
45. de Gramont A, Bosset JF, Milan C et al. A randomized trial comparing monthly low-dose leucovorin/fluorouracil bolus with bimonthly high-dose leucovorin/fluorouracil bolus plus continuous infusion for advanced colorectal cancer: A French intergroup study. J Clin Oncol 1997; 15: 808 15.
46. Köhne CH, Schöffski P, Wilke H et al. Effective biomodulation by leucovorin of high dose infusional fluorouracil given as a weekly 24-hour infusion: Results of a randomized trial in patients with advanced colorectal cancer. J Clin Oncol 1998; 16: 418 26.
47. Lorenz M, Staib-Sebler E, Gog C et al. A pilot study on intensive weekly 24-hour intra-arterial infusion with 5-fluorouracil and folinic acid for colorectal liver metastases. Oncology 1998; 55: 53-8.
48. Lorenz M, Hottenrott C, Maier P et al. Continuous regional treatment with fluoropyrimidines for metastases from colorectal carcinomas: Influence of modulation with leucovorin. Semin Oncol 1992; 19: 163-70.
49. Girard P, Ducreux M, Baldeyrou P et al. Surgery for lung metastases from colorectal cancer: Analysis of prognostic factors. J Clin Oncol 1996; 14: 2047-53.
50. Raab HR, Werner U, Hentjes B, Vogt P. Lokalrezidiv nach kolorektalem Karzinom: Ergebnisse der chirurgischen Therapie. In Schmoll HJ, Meyer HJ, Wilke H, Pichlmayr R (eds): Aktuelle Therapie Gastrointestinaler Tumoren. Berlin Heidelberg/New York: Springer Verlag 1992; 248 53.
51. Martin JK Jr, O'Connell MJ, Wieand HS et al. Intra-arterial floxuridine vs. systemic fluorouracil for hepatic metastases from colorectal cancer. A randomized trial. Arch Surg 1990; 125: 1022 7.
52. Kemeny N, Daly J, Reichman B et al. Intrahepatic or systemic infusion of fluorodeoxyuridine in patients with liver metastases from colorectal carcinoma. A randomized trial. Ann Intern Med 1987; 107: 459-65.
53. Chang AE, Schneider PD, Sugarbaker PH et al. A prospective randomized trial of regional versus systemic continuous 5-fluorodeoxyuridine chemotherapy in the treatment of colorectal liver metastases. Ann Surg 1987; 206: 685 93.
54. Bismuth H, Adam R, Levi F et al. Resection of nonresectable liver metastases from colorectal cancer after neoadjuvant chemotherapy. Ann Surg 1996; 224: 509-20.